Riot’s Bitfarms Bid Mirrors Vertex’s $10B Cash Playbook as BTC Dominance Hits 69.6%

Bitcoin was trading near $62,796 as of 03:20 UTC, with dominance at 69.6% and the total crypto market capitalization sitting close to $1.81 trillion, according to Coinotag’s data desk. The reading coincides with a broader all-cash acquisition wave that has now reached Bitcoin mining, where Riot Platforms is pursuing rival miner Bitfarms in a structure that closely tracks the mechanics of Vertex Pharmaceuticals’ $10 billion cash takeover of Crinetics Pharmaceuticals, announced Monday, July 6.

The Vertex-Crinetics blueprint

Vertex agreed to pay $85 per share in cash for Crinetics, roughly double the target’s closing price the day before the announcement, according to the company’s investor relations disclosure. The premium sent Crinetics shares to a fresh all-time high in a single session before the stock effectively pinned itself to the agreed takeover price — a pattern typical of all-cash deals, where speculation shifts almost entirely from the target’s standalone fundamentals to the certainty of deal completion.

Vertex’s actual target asset is Palsonify, a once-daily oral treatment for acromegaly, alongside a second late-stage drug for a separate rare hormonal disorder. Per the company’s own investor materials, the combined assets could generate more than $5 billion in annual peak sales — the assumption load-bearing the entire $10 billion valuation.

William Blair analyst Myles Minter flagged that the price tag only holds up if that peak-sales figure is actually reached, noting that despite the headline premium, Crinetics shares slipped 1.8% in after-hours trading. The reaction underscores a recurring tension in large cash-funded M&A: the market prices in deal certainty first and interrogates the underlying revenue math second.

Same choreography, Bitcoin mining sector

The same deal mechanics are now playing out in Bitcoin mining. Riot Platforms is pursuing Bitfarms, and Bitfarms shares have settled near the offer price — a convergence pattern that mirrors Crinetics’ post-announcement behavior almost exactly. Once a cash offer is public, the target effectively stops trading on its own growth story and converges toward the agreed consideration, leaving only a thin arbitrage spread and the tail risk that the transaction could unwind before an expected close.

For traders tracking miner equities alongside spot BTC, that convergence behavior is a signal in itself: it indicates the market is treating the Riot-Bitfarms situation as a near-certain close rather than a contested bid, with regulatory review, financing conditions and shareholder approval as the remaining checkpoints between announcement and completion, as is standard for cash-funded transactions of this size.

What the BTC tape shows

Against this consolidation backdrop, Bitcoin itself was changing hands around $62,846 on a daily basis, down roughly 0.82%, with the Fear and Greed Index reading 20 — Extreme Fear. Dominance at 69.6% suggests capital remains concentrated in BTC relative to altcoins even as the mining sector undergoes its own round of cash-driven M&A.

For desks positioning around miner equities, the read-through is that the Riot-Bitfarms structure now trades less on Bitfarms’ operating metrics and more on deal-completion odds — the same dynamic that flattened Crinetics’ post-announcement volatility in the biotech sector just days earlier.

Read more: 328,372 BTC US Reserve Frozen as Treasury, Commerce Clash Over Custody